DEREGULATION OF TFAM EXPRESSION PROMOTES MITOCHONDRIAL DAMAGE AND FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS

Zhou X, Trinh MT, TRAN MANH C, Giessl A, Bergmann C, Györfi AH, Schett G, Distler J (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 1195-1195

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.2085

Authors with CRIS profile

Xiang Zhou Department of Medicine 3 – Rheumatology and Immunology Minh Thuong Trinh Department of Medicine 3 – Rheumatology and Immunology CUONG TRAN MANH Department of Medicine 3 – Rheumatology and Immunology Andrea-Hermina Györfi Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

How to cite

APA:

Zhou, X., Trinh, M.T., TRAN MANH, C., Giessl, A., Bergmann, C., Györfi, A.-H.,... Distler, J. (2022). DEREGULATION OF TFAM EXPRESSION PROMOTES MITOCHONDRIAL DAMAGE AND FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1195-1195). LONDON: BMJ PUBLISHING GROUP.

MLA:

Zhou, Xiang, et al. "DEREGULATION OF TFAM EXPRESSION PROMOTES MITOCHONDRIAL DAMAGE AND FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 1195-1195.

BibTeX: Download